


|

| Feverfew |
 |
| (Tanacetum
parthenium) |
|
Feverfew is used mainly for the prevention
of migraine headaches and as an anti-inflammatory in rheumatoid arthritis.
It is also claimed to be useful for treatment of psoriasis, toothache,
insect bites, asthma, stomach ache, and menstrual problems; use as a antipyretic.
|
| Anti-inflammatory,
rheumatoid arthritis: |
Pattrick, 1989 |
| Migraine headache
prevention: |
Johnson, 1985 |
| Standardized: |
0.9%
standardized extract containing Parthenolide
2.25mg
1 capsule with water 3 x daily
|
| Whole Herb: |
(Leaf powder)
350mg
1 capsule with water 3 x daily
|
|
Summary:
Feverfew contains a number of compounds
with anti-inflammatory and smooth muscle relaxant activities. It has
increased in popularity in recent years, particularly for migraines.
Since the effects of this herb may take several weeks of continuous
therapy, individuals should be encouraged to use the herb for a minimum
of 1 month before determining whether it has been effective. The main
active ingredients are the sesquiterpene lactones, particularly parthenolide,
which inhibits serotonin release by human platelets in vitro. This may
be the mechanism of action for the herb's purported efficacy in treating
migraines. Parthenolide also inhibits serotonin release. Extracts of
Feverfew contain chemicals that inhibit activation of polymorphonuclear
leukocytes and the synthesis of leukotrienes and prostaglandins.
|
|
Pharmacology:
Feverfew reportedly inhibits the synthesis
of leukotrienes, prostaglandins, and thromboxanes which mediate inflammation.
In addition, Feverfew is claimed to inhibit platelet aggregation and
induce smooth muscle relaxation. It has been used most commonly for
migraine headaches. Feverfew has been claimed to relax uterine smooth
muscle and therefore should be avoided during pregnancy. It also may
inhibit platelet aggregation and blood coagulation.
|
|
Theoretical Cautions and Contraindications:
Use of Feverfew is contraindicated in
pregnancy or in individuals with allergies to members of the Asteraceae/Compositae
family (chrysanthemum, daisy). The onset of Feverfew's effects may be
delayed for several weeks. Abrupt discontinuation may increase migraine
frequency. A "post-Feverfew syndrome" has been described, including
nervousness, insomnia, joint stiffness and pain that may occur following
discontinuation in some individuals. Pharmacological activity may include
inhibition of platelet aggregation and increase in fibrinolytic activity.
Contraindicated in individuals with active bleeding (e.g., peptic ulcer,
intracranial bleeding). Use with caution in individuals with a history
of bleeding, hemostatic disorders, or drug-related hemostatic problems.
Use with caution if taking anticoagulant medications including warfarin,
aspirin, aspirin-containing products, NSAIDs, or antiplatelet agents
(e.g., ticlopidine, clopidogrel, dipyridamole). Feverfew should not
be used for longer than 4 months without medical supervision. "Post-feverfew"
syndrome has been reported with symptoms of nervousness, tension headaches,
insomnia, stiffness/pain in joints and tiredness. Feverfew is of the
ragweed family and cross-sensitivity might be possible. Discontinue
use for at least 14 days prior to dental or surgical procedures.
|
|
Theoretical Interactions:
Anticoagulants, aspirin, aspirin-containing
products, NSAIDs (may reduce effectiveness of feverfew), or antiplatelet
agents. Tannins in feverfew may inhibit iron absorption. Should not
be taken with blood thinners such as Coumadin.
|
|
Special Considerations:
Monitor for mouth ulcerations and encourage
the patient to report any unusual symptoms such as sores or ulcerations.
Encourage proper oral hygiene. Instruct the patient not to withdraw
the herb abruptly, but to taper its use gradually because of risk of
post-Feverfew syndrome.
|
|
References:
- Johnson ES, Kadam NP, Hylands DM,
et al, "Efficacy of Feverfew as Prophylactic Treatment of Migraine,"
Br Med J (Clin Res Ed), 1985, 291(6495): 569-73.
- Pattrick M, Heptinstall S, and Doherty
M, "Feverfew in Rheumatoid Arthritis: A Double-Blind Placebo Controlled
Study," Ann Rheum Dis, 1989, 48(7): 547-49.
- Ernst, E. "Harmless Herbs? A Review
of the Recent Literature" American Journal of Medicine,
vol. 104, 1998, pp.170-8.
- Klepser, T.B. and Klepser, M.E. "Unsafe
and Potentially Safe Herbal Therapies." American Journal of
Health-System Pharmacy, vol. 56, 1999, pp.125-38.
- Miller, L.G. "Herbal Medicinals:
Selected Clinical Considerations Focusing on Known or Poetential Drug-Herb
Interactions." Archives of Internal Medicine, vol. 158,
1998, pp. 2200-11.
- Zink, T. and Chaffin, J. "Healthy
'Health' Products: What Family Physicians Need To Know." American
Family Physician, vol 58, 1998, pp. 1133-1140.
- Short, R. (ed.), "Clinical Considerations
for Specific Herb-Drug Interactions & Potential Adverse Effects of
Herbs", Facts and Comparisons The Review of Natural Products,
St. Louis (Mo), 1998 Dec; 1-8.
- Fetrow, C.W., Avila, J. R., Complementary
& Alternative Medicines, Springhouse, PA, 1999.
- LaValle, J.B., Krinsky, D.L., Hawkins,
E.B, et. al., Natural Therapeutics Pocket Guide, Lexi-Comp,
USA, 2000.
- Gruenwald, J., Brendler, T., Jaenicke,
C., PDR for Herbal Medicines, 2nd Ed., Medical Economics Company,
NJ, 2000.
- Blumenthal M, Busse WR, Goldberg A,
Gruenwald J, Hall T, Riggins CW, Rister RS (eds.) The Complete
German Commission E Monographs: Therapeutic Guide to Herbal Medicines.
Klein S, Rister RS, translators. Austin (TX): American Botanical Council;
Boston (MA): Integrative Medicine Communications; 1998.
|
|
This information is not intended
to diagnose, treat, cure, or prevent any disease. Material herein is
derived from journals, textbooks, news releases, reference guides, etc.
Graham Development, Inc. cannot be held responsible for the validity
of the information contained in any reference noted herein or for the
misuse of information or any adverse effects by use of any stated materials
presented. ©2000 Scientific Herbals-unauthorized reproduction of
this document is prohibited.
|
|
Feverfew Standardized Herbal Supplement
| 14.99 |
|
|
Feverfew Herbal Supplement 350 mg
| 10.29 |
|
*Questions you should ask before purchasing any herbal supplement
7 Essentials to Health
Health
CONTENTS:
Home |
Colon Cleanse |
Complete Food |
Enzymes |
Essential C |
Greens |
Minerals |
Probiotics |
Michael Obrien |
Chi Machine® |
Chi Machine® Instructions |
Chi Machine® Testimonies |
Chi Machine® Benefits |
Chi Machine® Questions |
Aura |
Spine & Blood |
History |
Beware of CopyCats |
Opportunity |
Beta Loe |
Contact |
Articles |
Electro Reflex Energizer |
Fir-To-Go |
Chi Formula |
Bianca Body Profile |
Enzyme |
Enzymes |
Herbs |
HotHouse |
HotHouse Benefits |
HotHouse Features |
HotHouse Health Chart |
HotHouse Properties |
HotHouse Testimonials |
HotHouse Instructions |
7 Essentials |
7 Essentials Reviewed |
7 Pack Essentials Contents |
7 Pack Options |
Recommended Books |
Juicers |
Air Purifiers |
Symptoms |
Bath Products |
Bar Soaps |
Liquid Soaps |
Shampoo |
Affiliates |
Health Care or Doctor Care? |
Digestion |
Weight Loss |
Where are the Headlines?|
Enzymes and Weightloss |
Auto-Rehabilitation |
Oxygen and Tumor Humor |
Mental Health Patients |
Calisthenics |
Respiratory System |
Aerobic Exercise |
Insomnia |
The Power of Chi |
Healing from the Inside out |
Oxygenation |
Cardiopulmonary Disease |
Digestive Disorders |
Results Not Typical |
Riding the Cycles |
Astragalus |
Bilberry |
Black Cohosh |
Boswellia |
Bromelain |
Chasteberry |
Dong Quai |
Echinacea |
Feverfew |
Ginkgo Biloba |
Ginseng Panax |
Glucosamine |
Glucosamine Boswellia |
Goldenseal |
Gotukola |
Grapeseed |
Hawthorn |
Horsechestnut |
Kava Kava |
Milk Thistle |
Saw Palmetto |
St Johns Wort |
Turmeric |
Valerian |
Green Tea |
About Green Tea |
History of Green Tea |
Research
© 2001-2002 7Essentials.com
ALL RIGHTS RESERVED
726
|